In metabolic diseases such as obesity and type 2 diabetes, elevated RBP4 levels engage endothelial STRA6, initiating a signaling cascade independent of retinol nuclear activity. This evidence concerns the gene RBP4 and obesity due to melanocortin 4 receptor deficiency.